Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behringer

Showing results (1121-1130 of 1,187) with videos related to

Pageof 119
Sort By:
Annals of Emergency Medicine|January 20, 2025
Extracorporeal Cardiopulmonary Resuscitation: Outcomes Improve With Center ExperienceIngrid Magnet, Wilhelm Behringer, Felix Eibensteiner, et al.
Blood|April 2, 2026
Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase II GHSG NIVAHL TrialAnne Sophie Robertz, Ina Bühnen, Julia Meissner, et al.
Research Square|April 25, 2024
Inferring Bladder Cancer Evolution from Mucosal field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic MappingBogdan Czerniak, Sangkyou Lee, Sung Yun Jung, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|October 27, 2025
Jump performance and hop function, kinesiophobia and return to sports are important prognostic factors for a subsequent injury after an anterior cruciate ligament reconstruction: A 2-year follow-up cohort studyDaniel Niederer, Matthias Keller, Wolf Petersen, et al.
Nature Genetics|November 30, 2010
Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestineKenichiro Furuyama, Yoshiya Kawaguchi, Haruhiko Akiyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancerStephen Chan, Max E Scheulen, Stephen Johnston, et al.
Resuscitation|September 13, 2025
Delayed neurological recovery in patients after extracorporeal resuscitation compared to conventional resuscitation. Implications for outcome assessment after cardiac arrestIngrid Magnet, Christian Clodi, Florian Ettl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2024
Correlation between progression-free and overall survival in patients with Hodgkin lymphoma: a comprehensive analysis of individual patient data from randomized German Hodgkin Study Group (GHSG) trialsP J Bröckelmann, H Müller, M Fuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2013
Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapyJo Ann Janovick, M David Stewart, Darla Jacob, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb studyB Schultheis, D Reuter, M P Ebert, et al.
Pageof 119

Showing results (1121-1130 of 1,187) with videos related to

Sort By:
Pageof 119
Annals of Emergency Medicine|January 20, 2025
Extracorporeal Cardiopulmonary Resuscitation: Outcomes Improve With Center ExperienceIngrid Magnet, Wilhelm Behringer, Felix Eibensteiner, et al.
Blood|April 2, 2026
Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase II GHSG NIVAHL TrialAnne Sophie Robertz, Ina Bühnen, Julia Meissner, et al.
Research Square|April 25, 2024
Inferring Bladder Cancer Evolution from Mucosal field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic MappingBogdan Czerniak, Sangkyou Lee, Sung Yun Jung, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|October 27, 2025
Jump performance and hop function, kinesiophobia and return to sports are important prognostic factors for a subsequent injury after an anterior cruciate ligament reconstruction: A 2-year follow-up cohort studyDaniel Niederer, Matthias Keller, Wolf Petersen, et al.
Nature Genetics|November 30, 2010
Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestineKenichiro Furuyama, Yoshiya Kawaguchi, Haruhiko Akiyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancerStephen Chan, Max E Scheulen, Stephen Johnston, et al.
Resuscitation|September 13, 2025
Delayed neurological recovery in patients after extracorporeal resuscitation compared to conventional resuscitation. Implications for outcome assessment after cardiac arrestIngrid Magnet, Christian Clodi, Florian Ettl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2024
Correlation between progression-free and overall survival in patients with Hodgkin lymphoma: a comprehensive analysis of individual patient data from randomized German Hodgkin Study Group (GHSG) trialsP J Bröckelmann, H Müller, M Fuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2013
Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapyJo Ann Janovick, M David Stewart, Darla Jacob, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb studyB Schultheis, D Reuter, M P Ebert, et al.
Pageof 119